See also this year's filing and all EDGAR filings for this company.
PDF Report 0001355250_2020_Innovation_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | No LiabilitiesAndStockholdersEquity node found | input.sec.calculation_linkbase.edgar_model_mapping | {'lase_node': None, 'equity_node': None, 'partners_cap_node': None, 'nodes': "NodeView(('AssetsCurrent', 'Assets', 'OtherAssets', 'CashAndCashEquivalentsAtCarryingValue', 'PrepaidExpenseAndOtherAssetsCurrent', 'LiabilitiesCurrent', 'Liabilities', 'AccruedEnvironmentalLossContingenciesNoncurrent', 'OperatingLeaseLiabilityNoncurrent', 'AccountsPayableCurrent', 'AccruedLiabilitiesCurrent', 'AccruedSalariesCurrent', 'OperatingLeaseLiabilityCurrent', 'NotesPayableRelatedPartiesClassifiedCurrent', 'LoansPayableCurrent', 'AccruedDividendSeriesB5ConvertiblesPreferredStock', 'FiniteLivedPatentsGross', 'PropertyPlantAndEquipmentNet', 'SecurityDeposit'))"} |
Graph
Absolute values for 0001355250, Innovation Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 625,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,000 |
| 3 | remainder_Assets | 3,420,000 |
| 4 | LiabilitiesCurrent | 7,296,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 879,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,174,085 |
| 9 | ResearchAndDevelopmentExpense | 1,583,649 |
| 10 | remainder_Expenses | 4,605,119 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -7,410,034 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 4,046,000 |
| 1 | Liabilities | 8,175,000 |
| 2 | Expenses | 7,362,853 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -4,129,000 |
| 5 | NetIncome | -14,772,887 |
| 6 | ComprehensiveNetIncome | -14,772,887 |
| 7 | BaseVar | 13,496,944 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -3.89 |
| 9 | EconomicCapitalRatio | 0.420 |
Edgar->Model Mapping
Feature Distribution
Change over Time
